The Long Run with Luke Timmerman
Ep209: Mathai Mammen on Developing Drugs Against Undruggable Targets
Coming soon to iPhone. Already have it? “Listen in Starcast” takes you straight there.
On this episode
About this episode
Mathai Mammen, CEO of Cambridge, Mass.-based Parabilis Medicine, on developing alpha helical peptide molecules against hard targets of disease.